NASDAQ: PSTVPlus Therapeutics Inc Stock Ownership - Who owns Plus Therapeutics?
Insider buying vs selling
Have Plus Therapeutics Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Andrew John Hugh Macintyre Sims | Chief Financial Officer | 2025-11-04 | 20,000 | $0.51 | $10.20kBuy |
| Robert P. Lenk | Director | 2025-08-22 | 110,000 | $0.49 | $53.79kBuy |
PSTV insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when PSTV insiders and whales buy or sell their stock.
PSTV Shareholders
What type of owners hold Plus Therapeutics Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Kian Thiam Lim | 107.51% | 7,400,000 | $37.07M | Insider |
| Bank Sa Swissquote | 77.41% | 5,328,229 | $26.69M | Insider |
| Ag Postfinance | 66.00% | 4,543,086 | $22.76M | Insider |
| Olympus Corp | 58.30% | 4,013,043 | $20.11M | Insider |
| Vanguard Capital Management LLC | 35.26% | 2,427,098 | $12.16M | Institution |
| Geode Capital Management LLC | 29.29% | 2,016,314 | $10.10M | Institution |
| Blackrock Inc | 25.81% | 1,776,372 | $8.90M | Institution |
| Vanguard Fiduciary Trust Co | 16.91% | 1,163,776 | $5.83M | Institution |
| Marc H. Hedrick | 10.95% | 753,392 | $3.77M | Insider |
| State Street Corp | 6.81% | 468,893 | $2.35M | Institution |
PSTV vs Biotech Stocks
Plus Therapeutics Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.